Competent Cells Market report analyses the competent cells market by type, application, end user, and region. Apart from comprehensive geographic and product analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years.
The global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, competent cells market at a CAGR of 10.2%.
To know about the assumptions considered for the study, get sample copy@ www.reportsnreports.com/contacts/r…aspx?name=1133682
The electro competent cells segment is expected to register the highest CAGR during the forecast period
The competent cells market is classified on the basis of type into chemically competent cells and electro competent cells. Electro competent cells are expected to grow at the highest CAGR during the forecast period.
North America to account for the largest share of the market
Geographically, the competent cells market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017, and the trend is expected to continue during the forecast period.
The growth in this market can be attributed to the presence of major key players in the region, technological advancements, growth in the biotechnology and pharmaceutical industries, and increasing inclination towards research based on genomics and proteomics. Inquire For Complete Report Copy of Competent Cells Market by Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - Global Forecast to 2022 at www.reportsnreports.com/contacts/i…aspx?name=1133682
Advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins are some the key factors driving the growth of this market. On the other hand, increasing market consolidation creating strong entry barriers and high cost of competent cells kits are restraining the growth of this market.
Competent Cells Market Target Audience for this Report:
- Competent cell manufacturers
- Research instrument manufacturers
- Competent cell distributors
- Various research and consulting companies
- Research laboratories and research institutes
- Universities and CROs
“Competent Cells Market” spread across 214 pages, profiling 12 companies and supported with 162 tables and 32 figures is Direct Order this Report @ www.reportsnreports.com/purchase.aspx?name=1133682
*Top 25 Companies Analyzed for This Study are Merck KGaA (Germany) Promega Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S), New England Biolabs (U.S.), Takara Bio (Japan), Agilent Technologies (U.S.), Lucigen (Epicenter) (Illumina) (U.S.), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Bioline (U.K.), Zymo Research (U.S.), Beijing TransGen Biotech Co., Ltd. (China), Source BioScience (U.K.), IBA GmBH (Germany), Genewiz (U.S.), BioDynamics Laboratory, Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan), GeneScript Corporation (U.S.), Bio-Rad Laboratories (U.S.), Life Technologies (India) Pvt. Ltd., Cell Applications, Inc. (U.S.), Delphi Genetics (Belgium), Scarab Genomics, LLC (U.S.), and Yeastern Biotech Co., Ltd. (Taiwan).
Key Point from Table of Content
6 Competent Cells Market, By Type
6.2 Chemically Competent Cells
6.3 Electrocompetent Cells
7 Competent Cells Market, By Application
7.2.1 Subcloning & Routine Cloning
7.2.2 Phage Display Library Construction
7.2.3 Toxic/Unstable Dna Cloning
7.2.4 High-Throughput Cloning
7.3 Protein Expression
7.4 Other Applications
7.4.2 Large Plasmid Transformation
7.4.3 Single-Stranded Dna Production
7.4.4 Lentiviral Vector Production